214 related articles for article (PubMed ID: 29988738)
1. High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer.
Dai L; Pan G; Liu X; Huang J; Jiang Z; Zhu X; Gan X; Xu Q; Tan N
Cancer Manag Res; 2018; 10():1799-1806. PubMed ID: 29988738
[TBL] [Abstract][Full Text] [Related]
2. Prognosis significance and potential association between ALDOA and AKT expression in colorectal cancer.
Xu M; Xi S; Li H; Xia Y; Mei G; Cheng Z
Sci Rep; 2024 Mar; 14(1):6488. PubMed ID: 38499636
[TBL] [Abstract][Full Text] [Related]
3. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
[TBL] [Abstract][Full Text] [Related]
4. High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma.
Na N; Li H; Xu C; Miao B; Hong L; Huang Z; Jiang Q
Ther Clin Risk Manag; 2017; 13():279-285. PubMed ID: 28280347
[TBL] [Abstract][Full Text] [Related]
5. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of CCBE1 expression in human colorectal cancer.
Zhao YR; Liu H; Xiao LM; Jin CG; Zhang ZP; Yang CG
Cancer Manag Res; 2018; 10():6581-6590. PubMed ID: 30555263
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer.
Ma Z; Lian J; Yang M; Wuyang J; Zhao C; Chen W; Liu C; Zhao Q; Lou C; Han J; Zhang Y
Pathol Res Pract; 2019 Jun; 215(6):152383. PubMed ID: 30890279
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer].
Ma J; Chang W; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):336-341. PubMed ID: 29577224
[TBL] [Abstract][Full Text] [Related]
9. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
[TBL] [Abstract][Full Text] [Related]
10. Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target.
Chen L; Wu Z; Guo J; Wang X; Zhao Z; Liang H; Zhang R; Deng J
Clin Exp Med; 2023 Oct; 23(6):2443-2456. PubMed ID: 36422738
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of DEAD box helicase 5 and 17 are correlated with the progression and poor prognosis in gliomas.
Luo Q; Que T; Luo H; Meng Y; Chen X; Huang H; Hu R; Luo K; Zheng C; Yan P; Gong J; Fu H; Liu J; Tang Q; Huang G
Pathol Res Pract; 2020 Mar; 216(3):152828. PubMed ID: 32008867
[TBL] [Abstract][Full Text] [Related]
14. Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma.
Morimachi M; Hirabayashi K; Takanashi Y; Kawanishi A; Saika T; Ueyama Y; Nakagohri T; Nakamura N; Suzuki H; Kagawa T
J Clin Pathol; 2021 Nov; 74(11):741-745. PubMed ID: 33097588
[TBL] [Abstract][Full Text] [Related]
15. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
Jiang Z; Wang X; Li J; Yang H; Lin X
J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
[TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of DDX5 predicts recurrence and poor prognosis in breast cancer.
Li K; Zhao G; Yuan H; Zhang J; Li Q; Gong D; Lin P
Pathol Res Pract; 2022 Jan; 229():153736. PubMed ID: 34923193
[TBL] [Abstract][Full Text] [Related]
17. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
Saito Y; Takasawa A; Takasawa K; Aoyama T; Akimoto T; Ota M; Magara K; Murata M; Hirohashi Y; Hasegawa T; Sawada N; Saito T; Osanai M
Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
[TBL] [Abstract][Full Text] [Related]
18. High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma.
Tang Y; Yang X; Feng K; Hu C; Li S
J Gastrointest Oncol; 2021 Feb; 12(1):174-183. PubMed ID: 33708434
[TBL] [Abstract][Full Text] [Related]
19. Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
Shigematsu Y; Inamura K; Yamamoto N; Mise Y; Saiura A; Ishikawa Y; Takahashi S; Kanda H
BMC Cancer; 2018 Oct; 18(1):980. PubMed ID: 30326864
[TBL] [Abstract][Full Text] [Related]
20. DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway.
Xue Y; Jia X; Li L; Dong X; Ling J; Yuan J; Li Q
Biochem Biophys Res Commun; 2018 Sep; 503(4):2885-2891. PubMed ID: 30119889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]